Published in Drug Week, January 21st, 2011
The innovative study, which builds on UTHealth's growing portfolio of research using stem cell-based therapies for neurological damage, is led by principal investigator Charles S. Cox, the Children's Fund Distinguished Professor of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.